Trial in Progress: QUINTESSENTIAL—a Phase 2 study of Arlocabtagene Autoleucel (arlo-cel) in Patients with relapsed/refractory Multiple Myeloma (RRMM)Ciara L Freeman, Krina K. Patel, Sarah M. Larson et al.|Transplantation and Cellular Therapy|2026Cited by 0